Evidence map›Paper›PMID 34381047›Full record

ArticleNature communications2021

Malaria parasites both repress host CXCL10 and use it as a cue for growth acceleration.

Yifat Ofir-Birin, Hila Ben Ami Pilo, Abel Cruz Camacho, Ariel Rudik, Anna Rivkin, Or-Yam Revach, Netta Nir, Tal Block Tamin, Paula Abou Karam, Edo Kiper and 20 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Chloroquine induces eryptosis inFrontiers in cellular and infection microbiology · 2025
    Article
  8. Review
  9. Article
  10. Drug-induced stress mediatesMicrobiology spectrum · 2024
    Article
  11. Article
  12. CD8CNS neuroscience & therapeutics · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 8 institutions in 6 countries.

Yifat Ofir-BirinFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-3676-602X
Hila Ben Ami PiloFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Abel Cruz CamachoFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Ariel RudikFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Anna RivkinFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Or-Yam RevachFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Netta NirFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Tal Block TaminFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Paula Abou KaramFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Edo KiperFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Yoav PelegStructural Proteomics Unit, Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot, Israel.
Reinat NevoFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Aryeh SolomonDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
Tal Havkin-SolomonFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Alicia RojasFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Ron RotkopfDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-9503-7348
Ziv PoratFlow Cytometry Unit, Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-3059-181X
Dror AvniThe Institute of Geographic Medicine and Tropical Diseases and the Laboratory for Tropical Diseases Research, Sheba Medical Center, Ramat Gan, Israel.
Eli SchwartzThe Institute of Geographic Medicine and Tropical Diseases and the Laboratory for Tropical Diseases Research, Sheba Medical Center, Ramat Gan, Israel.
Thomas ZillingerInstitute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0002-0866-4835
Gunther HartmannInstitute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0003-1021-2018
Antonella Di PizioLeibniz-Institute for Food Systems Biology at the Technical University of Munich, Technical University of Munich, Freising, Germany.ORCID 0000-0002-8520-5165
Neils Ben QuashieEpidemiology Department, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Ghana.ORCID 0000-0002-2538-0324
Rivka DiksteinFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Motti GerlicDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ana Claudia TorrecilhasDepartment of Pharmaceutical Sciences, Federal University of São Paulo, UNIFESP, Diadema, Brazil.ORCID 0000-0001-5724-2199
Carmit LevyDepartment of Human Genetics and Biochemistry, Tel Aviv University, Tel Aviv, Israel.
Esther N M Nolte-'t HoenDepartment of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Andrew G BowieSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0001-5316-4373
Neta Regev-RudzkiFaculty of Biochemistry, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel. neta.regev-rudzki@weizmann.ac.il.ORCID 0000-0001-7252-0193
Weizmann Institute of Science · ILTel Aviv University · ILUniversity Hospital Bonn · DELeibniz-Institute for Food Systems Biology at the Technical University of Munich · DETrinity College Dublin · IEUniversidade Federal de São Paulo · BRUniversity of Ghana · GHUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogens are thought to use host molecular cues to control when to initiate life-cycle transitions, but these signals are mostly unknown, particularly for the parasitic disease malaria caused by Plasmodium falciparum. The chemokine CXCL10 is present at high levels in fatal cases of cerebral malaria patients, but is reduced in patients who survive and do not have complications. Here we show a Pf 'decision-sensing-system' controlled by CXCL10 concentration. High CXCL10 expression prompts P. falciparum to initiate a survival strategy via growth acceleration. Remarkably, P. falciparum inhibits CXCL10 synthesis in monocytes by disrupting the association of host ribosomes with CXCL10 transcripts. The underlying inhibition cascade involves RNA cargo delivery into monocytes that triggers RIG-I, which leads to HUR1 binding to an AU-rich domain of the CXCL10 3'UTR. These data indicate that when the parasite can no longer keep CXCL10 at low levels, it can exploit the chemokine as a cue to shift tactics and escape.

Indexed as

3' Untranslated RegionsChemokine CXCL10DEAD Box Protein 58ELAV-Like Protein 1Extracellular VesiclesHost-Parasite InteractionsHumansLife Cycle StagesMalaria, FalciparumMonocytesPlasmodium falciparumProtein BiosynthesisReceptors, ImmunologicRibosomesRNA, ProtozoanTHP-1 Cells3' Untranslated RegionsChemokine CXCL10CXCL10 protein, humanDEAD Box Protein 58ELAVL1 protein, humanELAV-Like Protein 1Receptors, ImmunologicRIGI protein, humanRNA, Protozoan

Identifiers

PMID34381047
PMCPMC8357946
OpenAlexW3189723842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.